nivolumab,adp-a2m4cd8
bms,adaptimmune therapeutics
['surpass', 'adaptimmune']
#icymi: we hosted a live virtual event to share data from the surpass #clinicaltrial presentation at and the next steps for the surpass family of trials. a replay of the event is available below. #cancer #immunotherapy
Adaptimmune is a multinational, clinical-stage #biotech company focused on developing novel immunotherapies that can potentially transform cancer treatment